SU011248 in Advanced Hepatocellular Carcinoma

NCT00361309 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma
Liver Cancer

Interventions

DRUG: SU011248

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]
[object Object]